United States Treasury Notes 3.88% | - | 32.38% | - | - | 32,331,000 |
MRNA US 07/18/25 C25 | - | 28.16% | - | - | 34,290 |
United States Treasury Notes 4.25% | - | 19.79% | - | - | 19,740,000 |
United States Treasury Bills 0% | - | 10.59% | - | - | 10,721,000 |
United States Treasury Bills 0% | - | 8.61% | - | - | 8,626,000 |
United States Treasury Notes 3% | - | 7.27% | - | - | 7,254,000 |
United States Treasury Bills 0% | - | 4.69% | - | - | 4,803,000 |
MRNA US 07/03/25 C30.5 | - | 0.59% | - | - | 15,700 |
MRNA US 07/11/25 C33 | - | 0.55% | - | - | 10,000 |
MRNA US 07/03/25 C30 | - | 0.54% | - | - | 8,590 |
Tidal Trust II - YieldMax MRNA Option Income Strategy ETF is an exchange traded fund launched and managed by Toroso Investments, LLC. The fund is co-managed by ZEGA Financial, LLC. The fund invests in public equity and fixed income markets of the United States. For its equity portion, it invests through derivatives in stocks of companies operating across healthcare, pharmaceutical, pharmaceutical products, biotechnology and life science sectors. The fund employs long/short strategy and uses derivatives such as options to create its portfolio. It invests in growth and value stocks of companies across diversified market capitalization. For its fixed income portion, the fund invests in short-term U.S. treasury securities. Tidal Trust II - YieldMax MRNA Option Income Strategy ETF was formed on October 23, 2023 and is domiciled in the United States.